Saturday, July 5, 2025 7/5/2025

Rural Drug Addiction Research (RDAR) Center - Phase 2

Award Number: P20GM130461
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/05/2019
PERIOD OF PERFORMANCE END DATE: 02/28/2029

Group Awards By:

View Award Description

Rural Drug Addiction Research (RDAR) Center - Phase 2 - PROJECT SUMMARY/ABSTRACT (OVERALL) The United States has been experiencing a national crisis around escalating rates of substance use and un- healthy behavior patterns in rural communities. The nature and challenge of substance misuse in community and rural settings continues to change rapidly, evolving in reaction to myriad forces. The causes and conse- quences of drug use are complex. They range from molecular to cultural and are usually studied in isolation even though they are interconnected. The unique mission of the Rural Drug Addiction Research (RDAR) Center is to apply complementary approaches across disciplines to better understand the factors associated with sub- stance use and identify new avenues to address this critical public heath challenge. In Phase 1, RDAR brought together basic and applied scientists from neuroscience, cognition, simulation, epidemiology, psychology, and sociology to address the etiology, assessment, prevention, and treatment of substance use. Center projects range from synapse to society—from the microscopic world of biology to social and geographical environments— to understand drug use in the Great Plains. In Phase 2, RDAR will extend its successful infrastructure and prac- tices to support a cadre of researchers that integrate multiple disciplines to enable promising early-stage inves- tigators to achieve research independence. The Center will support Project Leaders’ scientific growth and career development (Aim 1) and foster interdisciplinary research to investigate substance use (Aim 2) in Nebraska, the Great Plains, and surrounding regions. RDAR will draw on an internal Mentoring, Engagement, and Outreach Workgroup of 15 senior researchers providing dedicated mentoring and technical expertise. A 5-member Advi- sory Committee will guide the Center as leadership builds and strengthens the investigator pipeline through institutionally committed strategic hires, recruitment efforts across colleges and departments, institutional Pilot Project support, and collaborations with existing research centers and service units. Coupled with existing and new institutional commitments such as indirect recapture, pilot project funding, new tenure-track hires, and ren- ovated space, RDAR will enhance the success of investigators competing for external funding and increase the Center’s thematic footprint regarding basic, clinical, translational, and community research. These successes will position the Center to leverage Phase 2 funding and institutional commitments from a nationally recognized research university (University of Nebraska-Lincoln) and a university-based medical center (University of Ne- braska Medical Center) to increase RDAR’s scope of research and the reach of findings. Working with commu- nity, university, and IDeA-state partners, RDAR will engage with clinical, community health, and policy sectors to address substance use challenges in rural and underserved populations. These strategies will set the stage for national, evidence-based impact on this critical health issue, support the translation of research into inter- vention, enhance the foundation for long-term Center sustainability, and propel RDAR toward achieving funding as a NIDA/NIAAA-supported P01/P30/P50 research center.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $2,320,283 )
2025	2025	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST # 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	003	7	5/27/2025	NON-COMPETING CONTINUATION	$2,320,283
2025	2024	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST # 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	002	6	1/13/2025	COMPETING CONTINUATION	$1,770,134
2025	2024	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST # 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	000	6	12/18/2024	COMPETING CONTINUATION	$0
2025	2023	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST # 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	001	5	1/13/2025	NON-COMPETING CONTINUATION	-$1,770,134
														Subtotal = $2,320,283

Issue Date FY: 2024 ( Subtotal = $1,793,862 )
2024	2024	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	001	6	3/8/2024	COMPETING CONTINUATION	$1,793,862
2024	2023	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	002	5	3/26/2024	NON-COMPETING CONTINUATION	$0
2024	2023	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	000	5	1/8/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,793,862

Issue Date FY: 2023 ( Subtotal = $2,292,634 )
2023	2023	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST BOX 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	001	5	5/5/2023	NON-COMPETING CONTINUATION	$2,292,634
2023	2022	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST BOX 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	000	4	2/8/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,292,634

Issue Date FY: 2022 ( Subtotal = $2,292,634 )
2022	2022	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST BOX 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	001	4	6/20/2022	NON-COMPETING CONTINUATION	$229,265
2022	2022	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST BOX 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	000	4	3/24/2022	NON-COMPETING CONTINUATION	$2,063,369
														Subtotal = $2,292,634

Issue Date FY: 2021 ( Subtotal = $2,329,916 )
2021	2021	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST BOX 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	001	3	3/25/2021	NON-COMPETING CONTINUATION	$2,329,916
2021	2020	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST BOX 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	000	2	11/27/2020	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,329,916

Issue Date FY: 2020 ( Subtotal = $2,363,140 )
2020	2020	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST BOX 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	001	2	4/14/2020	NON-COMPETING CONTINUATION	$0
2020	2020	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST BOX 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	000	2	3/1/2020	NON-COMPETING CONTINUATION	$2,363,140
2020	2020	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST BOX 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	002	2	5/13/2020	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,363,140

Issue Date FY: 2019 ( Subtotal = $2,575,854 )
2019	2019	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	2200 VINE ST BOX 830861	LINCOLN	NE	68503	LANCASTER	USA	Biomedical Research and Research Training	000	1	4/5/2019	NEW	$2,575,854
														Subtotal = $2,575,854

Grand Total All Awards = $15,968,323

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Rural Drug Addiction Research (RDAR) Center - Phase 2

Award Number: P20GM130461

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/05/2019

PERIOD OF PERFORMANCE END DATE: 02/28/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer